ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.85
+0.03 (0.25%)
Nov 28, 2025, 4:00 PM EST - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.15 billion as of November 28, 2025. Its market cap has increased by 58.83% in one year.
Market Cap
1.15B
Enterprise Value
877.24M
1-Year Change
58.83%
Ranking
Category
Stock Price
$11.85
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.15B, an increase of 55.54%. That is a compound annual growth rate of 8.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.15B | 102.14% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 985.30B |
| Johnson & Johnson | 499.21B |
| AbbVie | 403.55B |
| UnitedHealth Group | 299.42B |
| AstraZeneca | 288.24B |
| Merck & Co. | 260.56B |
| Novartis AG | 248.38B |
| Abbott Laboratories | 223.38B |